AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
How a big biotech’s start-up gamble went wrong
Behind the Money
Introduction
Francis D'Souza, the CEO of Illumina at the time, spoke on an investor relations call in September 2020. The acquisition valued at $8 billion was presented as a way for Illumina to corner a new market in the realm of cancer screening and detection. PIGIM has over 1,400 investment professionals relentlessly research in pursuit of long-term goals.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode